Cancer - Companies Involved in Therapeutics Development AstraZeneca PLC Bayer AG Incuron, LLC Novartis AG Otsuka Holdings ..... Institutes, H2 2014 Salivary Gland Cancer - Pipeline by AstraZeneca PLC , H2 2014 Salivary Gland Cancer - Pipeline by Bayer
* AstraZeneca shares up 1.5 percent (Adds executive interview, consensus sales forecast, more reaction)
* PEGASUS-TIMI 54 study, a large scale outcomes trial involving over 21,000 patients, successfully met its primary efficacy endpoint
machines like NextSeq following shortly. Illumina has also announced gene panel test partnerships with Johnson & Johnson, AstraZeneca , Sanofi, and Amgen (for Vectibix). Management Faces a Tall Order in Sustaining Illumina's Leadership We rate Illumina’s stewardship rating
KARLSRUHE, Germany, Jan 13 (Reuters) - Britain's AstraZeneca Plc on Tuesday lost an appeal in Germany's Federal Court against generic drugmakers selling cheap copies of its anti-psychotic drug Seroquel XR.
LONDON, Jan 12 (Reuters) - AstraZeneca said on Monday its MedImmune biotech unit had struck a deal with unlisted U.S. company Omnis Pharmaceuticals on the development of cancer-fighting oncolytic viruses.
* MedImmune enters licensing agreement with Omnis Pharmaceuticals for oncolytic viruses in immuno-oncology
* Immune-boosting cancer drugs critical to company's future
add to its already long list of pipeline opportunities and strong commercialization partners (Sanofi, GSK, Roche, AstraZeneca , and Biogen). We are maintaining our no moat, positive trend rating as most of its pipeline is still unproven clinically
ABBV and Shire PLC SHPG. Further, the new environment makes it much less likely that Pfizer PFE will return to bid for AstraZeneca AZN following the failed attempt earlier in the year. However, the white knight acquisition of Allergan AGN by Actavis